NCT02135536 - Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Primary Biliary Cirrhosis

Interventions

BIOLOGICAL

NGM282

Trial Locations (17)

NGM Clinical Study Site 103, Phoenix

NGM Clinical Study Site 108, Coronado

NGM Clinical Study Site 101, Detroit

NGM Clinical Study Site 105, Durham

NGM Clinical Study Site 102, Dallas

NGM Clinical Study Site 113, San Antonio

NGM Clinical Study Site 602, Sydney

NGM Clinical Study Site 606, Sydney

NGM Clinical Study Site 609, Sydney

NGM Clinical Study Site 611, Sydney

NGM Clinical Study Site 614, Brisbane

NGM Clinical Study Site 607, Adelaide

NGM Clinical Study Site 608, Adelaide

NGM Clinical Study Site 601, Melbourne

NGM Clinical Study Site 613, Melbourne

NGM Clinical Study Site 401, Auckland

NGM Clinical Study Site 402, Christchurch